We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.74%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$19.4B
AUM Growth
+$2.92B
(+18%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
20.62%
Holding
1,394
New
273
Increased
343
Reduced
316
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$694M |
| 2 |
Philip Morris
PM
|
+$316M |
| 3 |
Johnson & Johnson
JNJ
|
+$315M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$235M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$248M |
| 2 |
Micron Technology
MU
|
+$212M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
+$196M |
| 4 |
Comcast
CMCSA
|
+$165M |
| 5 |
GSK
GSK
|
+$149M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.45% |
| 2 | Energy | 18.88% |
| 3 | Healthcare | 17.92% |
| 4 | Financials | 10.19% |
| 5 | Consumer Staples | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Targa Resources
TRGP
$56B
| $1.69M | 0.01% |
12,107
+3,806
| +46% | +$437K |
|
627
KRONOS Worldwide
KRO
$944M
| $1.68M | 0.01% |
107,284
+86,516
| +417% | +$1.34M |
|
628
Ashland
ASH
$3.33B
| $1.68M | 0.01% |
31,518
-266,642
| -89% | -$13.3M |
|
629
PBF Energy
PBF
$7.43B
| $1.64M | 0.01% |
61,638
+30,684
| +99% | +$908K |
|
630
Toro Company
TTC
$9.44B
| $1.64M | 0.01% |
+51,594
| New | +$1.65M |
|
|
WRES
631
DELISTED
WARREN RESOURCES INC
WRES
| $1.64M | 0.01% |
263,942
+2,751
| +1% | +$13.3K |
|
|
ARNA
632
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.63M | 0.01% |
+27,839
| New | +$1.75M |
|
|
TWTR
633
DELISTED
Twitter, Inc.
TWTR
| $1.63M | 0.01% |
39,659
-67,521
| -63% | -$2.56M |
|
|
LVNTA
634
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
| $1.62M | 0.01% |
44,788
-912,753
| -95% | -$28.7M |
|
|
VASC
635
DELISTED
Vascular Solutions Inc
VASC
| $1.62M | 0.01% |
73,133
+46,335
| +173% | +$1.01M |
|
|
MITL
636
DELISTED
Mitel Networks Corporation
MITL
| $1.58M | 0.01% |
149,984
-55,043
| -27% | -$564K |
|
|
HNP
637
DELISTED
Huaneng Power Intl, Inc.
HNP
| $1.57M | 0.01% |
+34,617
| New | +$1.43M |
|
|
FRP
638
DELISTED
Fairpoint Communications, Inc.
FRP
| $1.57M | 0.01% |
+112,105
| New | +$1.57M |
|
|
BCA
639
DELISTED
CORPBANCA SPONSORED ADR REPSTG (1-1,500)COM STK
BCA
| $1.56M | 0.01% |
+83,691
| New | +$1.52M |
|
640
Sturm, Ruger & Co
RGR
$598M
| $1.55M | 0.01% |
26,357
-5,658
| -18% | -$354K |
|
|
CCMP
641
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $1.54M | 0.01% |
+34,582
| New | +$1.5M |
|
642
TTM Technologies
TTMI
$14.8B
| $1.54M | 0.01% |
188,022
+61,876
| +49% | +$486K |
|
|
AAT
643
American Assets Trust
AAT
$1.39B
| $1.53M | 0.01% |
44,205
+26,531
| +150% | +$904K |
|
|
MN
644
DELISTED
MANNING & NAPIER, INC.
MN
| $1.52M | 0.01% |
88,203
-3,071
| -3% | -$51.5K |
|
645
AMN Healthcare
AMN
$1.38B
| $1.5M | 0.01% |
121,861
-129,549
| -52% | -$1.55M |
|
|
COWN
646
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $1.5M | 0.01% |
88,632
+71,472
| +417% | +$1.18M |
|
|
MCRL
647
DELISTED
MICREL INC
MCRL
| $1.49M | 0.01% |
132,208
+56,997
| +76% | +$614K |
|
648
TFS Financial
TFSL
$4.98B
| $1.47M | 0.01% |
103,287
-1,039,919
| -91% | -$14M |
|
|
KYO
649
DELISTED
Kyocera Adr
KYO
| $1.47M | 0.01% |
30,829
+1,054
| +4% | +$48.3K |
|
650
Norfolk Southern
NSC
$76.2B
| $1.47M | 0.01% |
+14,223
| New | +$1.4M |
|
Similar funds
VGA
Arrowstreet Capital's Q2 2014 Portfolio in Review
As of Q2 2014, Arrowstreet Capital held 1,394 positions worth $19.4B, up 18% from $16.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Arrowstreet Capital deployed $1.81B of net new capital in Q2 2014, opening 273 new positions and adding to 343 existing holdings. Its largest new stake was Johnson & Johnson: 3,117,484 shares worth $326M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Energy and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $248M trimmed.
- Arrowstreet Capital's largest Q2 2014 buy was Johnson & Johnson: 3,117,484 shares worth $326M.
- Arrowstreet Capital added most to Apple in Q2 2014, an estimated $694M increase.
- Arrowstreet Capital's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $248M.
- Arrowstreet Capital fully exited Comcast in Q2 2014, selling an estimated $165M.
- Arrowstreet Capital's ten largest holdings make up 21% of its $19.4B portfolio in Q2 2014.
- Arrowstreet Capital opened 273 new positions and closed 453 in Q2 2014.
- Arrowstreet Capital's portfolio value rose 18% quarter-over-quarter to $19.4B.
Based on Arrowstreet Capital's 13F filing for Q2 2014, filed 14 Aug 2014.